当前位置: X-MOL 学术Jpn. J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy
Japanese Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2021-09-06 , DOI: 10.1093/jjco/hyab141
Toshio Takagi 1 , Kazuhiko Yoshida 1 , Tsunenori Kondo 2 , Hironori Fukuda 1 , Hiroki Ishihara 1 , Hirohito Kobayashi 1 , Junpei Iizuka 1 , Hideki Ishida 1 , Kazunari Tanabe 1
Affiliation  

We investigated the incidence of hypopituitarism in Japanese patients with metastatic renal cell carcinoma (mRCC) who received ipilimumab and nivolumab (I-P) therapy and compared patient characteristics and survival rates between patients with hypopituitarism and those without.

中文翻译:

易普利姆玛和纳武单抗联合治疗转移性肾细胞癌患者的垂体功能减退症

我们调查了接受易普利姆玛和纳武单抗 (IP) 治疗的日本转移性肾细胞癌 (mRCC) 患者的垂体功能减退症的发生率,并比较了垂体功能减退症患者和没有垂体功能减退症患者的患者特征和存活率。
更新日期:2021-09-06
down
wechat
bug